Found 6 matching trials
CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers PHASE1 A randomized open-label, multiple dose, three-treatment, three-period, six-...
Show More Learn More & Join Trial
Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin PHASE1 Monotherapies for lowering LDL-C often do not achieve target lipid levels b...
Show More Learn More & Join Trial
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (ā„ 200 and < 500 mg/dL) PHASE3 The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Show More Location
Amarin Investigational Site
Learn More & Join Trial
A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin PHASE1 Monotherapies for lowering LDL-C often do not achieve target lipid levels b...
Show More Learn More & Join Trial
A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032) PHASE3 The purpose of this study was to evaluate the long-term safety and tolerabi...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ℠500 and ⤠2000 mg/dL PHASE3 The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Show More Location
Amarin Investigational Site
Learn More & Join Trial